Abbott Laboratories Statistics Share Statistics Abbott Laboratories has 1.74B
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 1.74B Shares Change (YoY) 0% Shares Change (QoQ) 0.32% Owned by Institutions (%) 77.09% Shares Floating 1.73B Failed to Deliver (FTD) Shares 91,618 FTD / Avg. Volume 1.38%
Short Selling Information The latest short interest is 19.06M, so 1.1% of the outstanding
shares have been sold short.
Short Interest 19.06M Short % of Shares Out 1.1% Short % of Float 1.1% Short Ratio (days to cover) 3.77
Valuation Ratios The PE ratio is 14.62 and the forward
PE ratio is 23.7.
Abbott Laboratories's PEG ratio is
0.11.
PE Ratio 14.62 Forward PE 23.7 PS Ratio 4.67 Forward PS 4.7 PB Ratio 4.11 P/FCF Ratio 30.84 PEG Ratio 0.11
Financial Ratio History Enterprise Valuation Abbott Laboratories has an Enterprise Value (EV) of 203.53B.
EV / Sales 4.85 EV / EBITDA 18.79 EV / EBIT 23.78 EV / FCF 32.05
Financial Position The company has a current ratio of 1.67,
with a Debt / Equity ratio of 0.32.
Current Ratio 1.67 Quick Ratio 1.23 Debt / Equity 0.32 Debt / EBITDA 1.41 Debt / FCF 2.41 Interest Coverage 11.36
Financial Efficiency Return on Equity is 28.12% and Return on Invested Capital is 18.97%.
Return on Equity 28.12% Return on Assets 16.46% Return on Invested Capital 18.97% Revenue Per Employee $367.98K Profits Per Employee $117.56K Employee Count 114,000 Asset Turnover 0.52 Inventory Turnover 3.33
Taxes Income Tax -6.39B Effective Tax Rate -91.1%
Stock Price Statistics The stock price has increased by 21.83% in the
last 52 weeks. The beta is 0.7, so Abbott Laboratories's
price volatility has been higher than the market average.
Beta 0.7 52-Week Price Change 21.83% 50-Day Moving Average 131.72 200-Day Moving Average 126.12 Relative Strength Index (RSI) 62.3 Average Volume (20 Days) 6,623,325
Income Statement In the last 12 months, Abbott Laboratories had revenue of 41.95B
and earned 13.4B
in profits. Earnings per share was 7.74.
Revenue 41.95B Gross Profit 21.32B Operating Income 6.85B Net Income 13.4B EBITDA 10.83B EBIT 7.62B Earnings Per Share (EPS) 7.74
Full Income Statement Balance Sheet The company has 7.62B in cash and 15.28B in
debt, giving a net cash position of -7.66B.
Cash & Cash Equivalents 7.62B Total Debt 15.28B Net Cash -7.66B Retained Earnings 47.26B Total Assets 81.45B Working Capital 10.15B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 8.56B
and capital expenditures -2.21B, giving a free cash flow of 6.35B.
Operating Cash Flow 8.56B Capital Expenditures -2.21B Free Cash Flow 6.35B FCF Per Share 3.67
Full Cash Flow Statement Margins Gross margin is 50.83%, with operating and profit margins of 16.33% and 31.95%.
Gross Margin 50.83% Operating Margin 16.33% Pretax Margin 16.72% Profit Margin 31.95% EBITDA Margin 25.83% EBIT Margin 16.33% FCF Margin 15.14%
Dividends & Yields ABT pays an annual dividend of $2.87,
which amounts to a dividend yield of 1.76%.
Dividend Per Share $2.87 Dividend Yield 1.76% Dividend Growth (YoY) 7.27% Payout Ratio 35.96% Earnings Yield 6.84% FCF Yield 3.24%
Dividend Details Analyst Forecast The average price target for ABT is $145,
which is 10.4% higher than the current price. The consensus rating is "Buy".
Price Target $145 Price Target Difference 10.4% Analyst Consensus Buy Analyst Count 17
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $193.5 Lynch Upside 47.34% Graham Number 69.23 Graham Upside -47.29%
Stock Splits The last stock split was on Jan 2, 2013. It was a
forward
split with a ratio of 5000:2399.
Last Split Date Jan 2, 2013 Split Type forward Split Ratio 5000:2399
Scores Altman Z-Score 6.17 Piotroski F-Score 4
